Companies /Healthcare

Illumina Inc

NASDAQ: ILMN Diagnostics & Research
$279.47
▲ $8.43 (+3.11%) today
Markets closed · 8:37pm ET
24/7 Rating BUY
Our 12-month price target
$303.76
+8.7% upside by Oct 2027
Price when calculated $279.47 Oct 27, 2026
Street consensus $248.90 21 analysts
Ours vs. the Street +22.0% Our target vs. consensus

Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.

How we calculate it →
12-Month Projection Historical Optimistic Target Conservative
$140$210$280Oct 2025Oct 2027Oct 27$322.89$303.76$218.18
$140$210$280Oct 2025Oct 2027Oct 27$322.89$303.76$218.18

Analyst Sentiment

21ANALYSTS
Buy1152%
Hold629%
Sell419%
The Bottom Line

Illumina appears attractively valued at current levels. With a 8.7% upside to our $303.76 target, the risk-reward profile looks favorable for investors with a 12-month time horizon. Wall Street agrees, with 52% of analysts rating it a Buy.

The 24/7 Factor

Base Growth
Conservative growth baseline (reduced to avoid double-counting P/E growth)
1.05×
Sector Momentum
Defensive growth with aging population tailwinds
1.10×
Analyst Consensus
Moderate analyst optimism
+2.0%
Earnings Growth
Earnings pressure
−0.9%
Volatility Adjustment
Higher volatility stock
−0.8%
Price Position
Upper range of 52-week trading
+0.5%
Read our full methodology →

5-Year Projection

Long-Term Forecast Optimistic Target Conservative
$210$280$350$420’26’27’28’29’30’31$418.32$386.43$208.74
$210$280$350$420’26’27’28’29’30’31$418.32$386.43$208.74

Prediction History

ILMN Price Target History Our Target Stock Price
$200$240$280Jul 31Oct 23$295.70$269.42
$200$240$280Jul 31Oct 23$295.70$269.42
Date Price Target Stock Price Rating Upside
$295.70 $269.42 BUY +9.8%
$286.61 $262.54 BUY +9.2%
$295.88 $278.17 BUY +6.4%
$285.25 $273.04 HOLD +4.5%
$280.15 $270.00 HOLD +3.8%
$250.58 $239.62 HOLD +4.6%
$219.81 $206.45 BUY +6.5%
$227.67 $218.22 HOLD +4.3%

Frequently Asked Questions

What is the ILMN stock price prediction for 2030?

Looking ahead to 2030, our model projects ILMN could trade at an average price of $362.18, with a potential range between $271.63 and $452.72. This represents a potential 29.6% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.

Is ILMN a buy, sell, or hold right now?

24/7 Wall St. currently rates ILMN as a BUY. Moderate upside (+8.7%) Among Wall Street analysts, 11 rate it Buy, 6 rate it Hold, and 4 rate it Sell.

What is the ILMN stock price target in an optimistic scenario?

In our optimistic scenario for ILMN, the stock could reach $322.89 over the next 12 months, representing a 15.5% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.

What is the downside risk for ILMN stock?

In our conservative scenario, ILMN could trade as low as $218.18 over the next 12 months, representing a 21.9% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.

Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →